Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
NEWARK, Del.–(BUSINESS WIRE)–Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today announced a majority investment by Curewell Capital (“Curewell”), a Los…